Home / Resource Library / 5-YEAR UPDATE ON FRONTLINE BRENTUXIMAB VEDOTIN WITH AVD FOR STAGE II-IV HIV-ASSOCIATED CLASSICAL HODGKIN LYMPHOMA (AMC-085)5-YEAR UPDATE ON FRONTLINE BRENTUXIMAB VEDOTIN WITH AVD FOR STAGE II-IV HIV-ASSOCIATED CLASSICAL HODGKIN LYMPHOMA (AMC-085) ICML 2025